Mabrouk Sobhy , Tamer Elsamahy , Esraa A. Abdelkarim , Ebtihal Khojah , Haiying Cui , Lin Lin
{"title":"Cardamom essential oil-loaded zinc oxide nanoparticles: A sustainable antimicrobial strategy against multidrug-resistant foodborne pathogens","authors":"Mabrouk Sobhy , Tamer Elsamahy , Esraa A. Abdelkarim , Ebtihal Khojah , Haiying Cui , Lin Lin","doi":"10.1016/j.micpath.2025.107661","DOIUrl":null,"url":null,"abstract":"<div><div>The globalization of the food trade has escalated challenges in ensuring food safety due to foodborne pathogens, including multidrug-resistant (MDR) strains, which pose significant public health risks and economic burdens. Innovative antimicrobial strategies are urgently required. In this study, cardamom essential oil-loaded zinc oxide nanoparticles (CEO-ZnO-NPs) were synthesized and evaluated for their antimicrobial potential and mechanisms of action against MDR <em>Escherichia coli</em> and <em>Staphylococcus aureus</em>. Dynamic light scattering and the transmission electron microscopy (TEM) micrograph confirmed a spherical nanocomposite with an average size of 141.4 nm with good dispersion and stability over 180 days. Antimicrobial activity assessed via the agar well diffusion method showed dose-dependent inhibition, with zones of 25.75 ± 0.90 mm for <em>E. coli</em> and 31.05 ± 0.46 mm for <em>S. aureus</em> at 400 μg/mL. Minimum inhibitory concentrations (MIC) were 25 μg/mL (<em>E. coli</em>) and 12.5 μg/mL (<em>S. aureus</em>), while minimum bactericidal concentrations (MBC) were 50 μg/mL and 25 μg/mL, respectively. Kill-time analysis revealed a marked reduction in bacterial viability after 120 min of exposure. Mechanistic studies using scanning electron microscopy showed structural damage, including disrupted membranes and cell shrinkage. Also, protein levels significantly decreased, with DNA and ATP levels reduced by 74.51 % and 91.15 % in <em>E. coli</em> and 79.40 % and 90.81 % in <em>S. aureus</em>. Enzymatic activities, including ATPase and alkaline phosphatase, were inhibited by up to 84.63 %. In addition, the low cytotoxicity of CEO-ZnO-NPs against Vero cells supporting their potential biosafety for food safety applications. These findings demonstrate that CEO-ZnO-NPs disrupt bacterial processes such as protein synthesis, membrane integrity, and enzymatic activity, offering a promising approach that aligns with the United Nations Sustainable Development Goals (SDGs), particularly SDGs 2, 3, and 12, while promoting circular economy principles by reducing reliance on synthetic preservatives to address antimicrobial resistance in foodborne pathogens.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"205 ","pages":"Article 107661"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025003869","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The globalization of the food trade has escalated challenges in ensuring food safety due to foodborne pathogens, including multidrug-resistant (MDR) strains, which pose significant public health risks and economic burdens. Innovative antimicrobial strategies are urgently required. In this study, cardamom essential oil-loaded zinc oxide nanoparticles (CEO-ZnO-NPs) were synthesized and evaluated for their antimicrobial potential and mechanisms of action against MDR Escherichia coli and Staphylococcus aureus. Dynamic light scattering and the transmission electron microscopy (TEM) micrograph confirmed a spherical nanocomposite with an average size of 141.4 nm with good dispersion and stability over 180 days. Antimicrobial activity assessed via the agar well diffusion method showed dose-dependent inhibition, with zones of 25.75 ± 0.90 mm for E. coli and 31.05 ± 0.46 mm for S. aureus at 400 μg/mL. Minimum inhibitory concentrations (MIC) were 25 μg/mL (E. coli) and 12.5 μg/mL (S. aureus), while minimum bactericidal concentrations (MBC) were 50 μg/mL and 25 μg/mL, respectively. Kill-time analysis revealed a marked reduction in bacterial viability after 120 min of exposure. Mechanistic studies using scanning electron microscopy showed structural damage, including disrupted membranes and cell shrinkage. Also, protein levels significantly decreased, with DNA and ATP levels reduced by 74.51 % and 91.15 % in E. coli and 79.40 % and 90.81 % in S. aureus. Enzymatic activities, including ATPase and alkaline phosphatase, were inhibited by up to 84.63 %. In addition, the low cytotoxicity of CEO-ZnO-NPs against Vero cells supporting their potential biosafety for food safety applications. These findings demonstrate that CEO-ZnO-NPs disrupt bacterial processes such as protein synthesis, membrane integrity, and enzymatic activity, offering a promising approach that aligns with the United Nations Sustainable Development Goals (SDGs), particularly SDGs 2, 3, and 12, while promoting circular economy principles by reducing reliance on synthetic preservatives to address antimicrobial resistance in foodborne pathogens.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)